Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1660437rdf:typepubmed:Citationlld:pubmed
pubmed-article:1660437lifeskim:mentionsumls-concept:C0023473lld:lifeskim
pubmed-article:1660437lifeskim:mentionsumls-concept:C1513388lld:lifeskim
pubmed-article:1660437lifeskim:mentionsumls-concept:C0031525lld:lifeskim
pubmed-article:1660437pubmed:issue3lld:pubmed
pubmed-article:1660437pubmed:dateCreated1992-1-14lld:pubmed
pubmed-article:1660437pubmed:abstractTextIn virtually all Ph1 chromosome-positive CML patients, the breakpoint on chromosome 22 maps in a very restricted area of 5.8 Kb, which has been named "breakpoint cluster region" or "bcr". Several molecular probes of this region are presently available, and this makes the molecular diagnosis of CML a useful approach which can be particularly important in those cases in which cytogenetic analysis does not reveal the presence of a Ph1 chromosome. Here we report the problems and our experience during the molecular analysis of the 478 patients examined so far.lld:pubmed
pubmed-article:1660437pubmed:languageenglld:pubmed
pubmed-article:1660437pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660437pubmed:citationSubsetIMlld:pubmed
pubmed-article:1660437pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660437pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660437pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660437pubmed:statusMEDLINElld:pubmed
pubmed-article:1660437pubmed:issn0390-6078lld:pubmed
pubmed-article:1660437pubmed:authorpubmed-author:RossoCClld:pubmed
pubmed-article:1660437pubmed:authorpubmed-author:TuraSSlld:pubmed
pubmed-article:1660437pubmed:authorpubmed-author:ZaccariaAAlld:pubmed
pubmed-article:1660437pubmed:authorpubmed-author:GuerrasioAAlld:pubmed
pubmed-article:1660437pubmed:authorpubmed-author:BuzziMMlld:pubmed
pubmed-article:1660437pubmed:authorpubmed-author:Lo CocoFFlld:pubmed
pubmed-article:1660437pubmed:authorpubmed-author:DiverioDDlld:pubmed
pubmed-article:1660437pubmed:authorpubmed-author:TestoniNNlld:pubmed
pubmed-article:1660437pubmed:authorpubmed-author:TassinariAAlld:pubmed
pubmed-article:1660437pubmed:authorpubmed-author:CelsoBBlld:pubmed
pubmed-article:1660437pubmed:issnTypePrintlld:pubmed
pubmed-article:1660437pubmed:volume76lld:pubmed
pubmed-article:1660437pubmed:geneSymbolABLlld:pubmed
pubmed-article:1660437pubmed:geneSymbolBCRlld:pubmed
pubmed-article:1660437pubmed:ownerNLMlld:pubmed
pubmed-article:1660437pubmed:authorsCompleteNlld:pubmed
pubmed-article:1660437pubmed:pagination183-7lld:pubmed
pubmed-article:1660437pubmed:dateRevised2010-3-24lld:pubmed
pubmed-article:1660437pubmed:meshHeadingpubmed-meshheading:1660437-...lld:pubmed
pubmed-article:1660437pubmed:meshHeadingpubmed-meshheading:1660437-...lld:pubmed
pubmed-article:1660437pubmed:meshHeadingpubmed-meshheading:1660437-...lld:pubmed
pubmed-article:1660437pubmed:meshHeadingpubmed-meshheading:1660437-...lld:pubmed
pubmed-article:1660437pubmed:meshHeadingpubmed-meshheading:1660437-...lld:pubmed
pubmed-article:1660437pubmed:meshHeadingpubmed-meshheading:1660437-...lld:pubmed
pubmed-article:1660437pubmed:meshHeadingpubmed-meshheading:1660437-...lld:pubmed
pubmed-article:1660437pubmed:meshHeadingpubmed-meshheading:1660437-...lld:pubmed
pubmed-article:1660437pubmed:meshHeadingpubmed-meshheading:1660437-...lld:pubmed
pubmed-article:1660437pubmed:meshHeadingpubmed-meshheading:1660437-...lld:pubmed
pubmed-article:1660437pubmed:meshHeadingpubmed-meshheading:1660437-...lld:pubmed
pubmed-article:1660437pubmed:articleTitleMolecular diagnosis of Philadelphia chromosome-positive chronic myeloid leukemia.lld:pubmed
pubmed-article:1660437pubmed:affiliationIstituto di Ematologia Lorenzo e Ariosto Seràgnoli, Università di Bologna, Italy.lld:pubmed
pubmed-article:1660437pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1660437pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed